Company profile

Intarcia

Intarcia has raised $1.89 billion across multiple rounds, including a $525M Series J (Aug 03, 2017), an $8M Series J (Jan 17, 2018) and a $198M Series J. Founded in 1995, Intarcia developed an implantable osmotic pump that delivers therapeutic drugs subcutaneously over extended periods targeting diabetes and other chronic conditions. Investment supported clinical trials, device engineering, regulatory submissions and scale manufacturing.

Back to profiles

Quick facts

Total funding: $1.89 billion
Founded: 1995

Reach buyers like Intarcia on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like Intarcia
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like Intarcia.

The 14-day trial ships every feature, no card required.

Start free →